Trastuzumab in combination with cisplatin and gemcitabine in patients with Her2-overexpressing, untreated, advanced non-small cell lung cancer: Report of a phase II trial and findings regarding optimal identification of patients with Her2-overexpressing disease

Ralph G. Zinner, Bonnie S. Glisson, Frank V. Fossella, Katherine M.W. Pisters, Merril S. Kies, Pamela M. Lee, Erminia Massarelli, Bradley Sabloff, Herbert A. Fritsche, Jae Y. Ro, Nelson G. Ordonez, Hai T. Tran, Ying Yang, Terry L. Smith, Robert D. Mass, Roy S. Herbst

Research output: Contribution to journal › Article › peer-review

126 Scopus citations

Fingerprint

Dive into the research topics of 'Trastuzumab in combination with cisplatin and gemcitabine in patients with Her2-overexpressing, untreated, advanced non-small cell lung cancer: Report of a phase II trial and findings regarding optimal identification of patients with Her2-overexpressing disease'. Together they form a unique fingerprint.

Medicine & Life Sciences